(Q44532971)

3 December 2017

title

Selective cyclooxygenase-2 inhibitors and relapse of inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

3 December 2017

main subject

1 reference

Livia Biancone

1

1 reference

3 December 2017

Claudio Tosti

2

1 reference

3 December 2017

Francesca De Nigris

3

1 reference

3 December 2017

Massimo Fantini

4

1 reference

3 December 2017

Francesco Pallone

5

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

3 December 2017

1 reference

3 December 2017

volume

125

1 reference

3 December 2017

issue

2

1 reference

3 December 2017

page(s)

637-638

1 reference

COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900983-1

Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900983-1

Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900983-1

Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900983-1

Exacerbation of inflammatory bowel disease associated with use of celecoxib

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900983-1

10.1016/S0016-5085(03)00983-1

7 January 2021

Identifiers

DOI

1 reference

3 December 2017

1 reference